Eulerpool Terminal
The edge that pays for itself.
Current Relmada Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
9.18 USD
+94.08 %
Median
9.18 USD
+94.08 %
Max
10.50 USD
Min
8.08 USD
Last Price
4.73 USD
Buy
8
Hold
1
Sell
0
The average target price for Relmada Therapeutics is 9.18 USD. (+94.08 % above the current price)
The median price target of Relmada Therapeutics is 9.18 USD.
Stock analysts from many renowned investment banks are closely examining the Relmada Therapeutics stock. They conclude their professional Relmada Therapeutics stock analyses with a clear recommendation for the Relmada Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 8 | 1 | 0 | — |
| 2026-02-01 | 8 | 1 | 0 | 9.18 USD |
| 2026-02-01 | 8 | 1 | 0 | 10.20 USD |
| 2026-01-01 | 7 | 1 | 0 | 10.20 USD |
| 2025-12-01 | 6 | 2 | 0 | 10.20 USD |
| 2025-12-01 | 6 | 2 | 0 | 10.20 USD |
Relmada Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Relmada Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 10.00 M USD | -24.00 M USD | -0.35 USD |
| 2027e | 32.00 M USD | -29.00 M USD | -0.42 USD |
| 2028e | 12.00 M USD | -28.00 M USD | -0.41 USD |